Business Parks & Science Centres

 
 
 

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Organisation › Details

Trianta Immunotherapies GmbH

Trianta Immunotherapies GmbH, a wholly owned subsidiary of Medigene AG, is at the forefront of personalized T cell immunotherapy, focussing on next generation antigen-tailored dendritic cell (DC) vaccines, T cell receptor (TCR)-based adoptive cell therapy and T cell-targeted antibodies (TABs). Trianta Immunotherapies was founded late 2013 as a spin-off of the Helmholtz Zentrum München, the German Research Centre for Environmental Health. Trianta exploits the therapeutic and commercial potential of T cell-focused therapies developed by the team of Prof. Dolores J. Schendel at the Helmholtz Zentrum Munich, in collaboration with Prof. Thomas Blankenstein at the Max Delbrück Centre for Molecular Medicine, Berlin. The team of Trianta pursues three complementary immunotherapeutic strategies to target various tumour types and stages. Each one is focused on T cells, a type of white blood cell that plays a pivotal role in immunity. Trianta Immunotherapies was acquired by Medigene in January 2014. *

 

Period Start 2013-10-08 splitoff
Period End 2014-11-07 renamed
  Group Medigene (Group)
  Today Medigene Immunotherapies GmbH
  Predecessor Helmholtz-Zentrum München – Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (HMGU)
  Successor Medigene Immunotherapies GmbH
Products Industry cancer immunotherapy (immuno-oncology, I-O)
  Industry 2 TCR engineering technology (T-cell receptor engineering technology)
Person Person Schendel, Dolores J. (Medigene 201602– CEO before CMO before Trianta Immunotherapies + HelmholtzZentrum München)
     
Region Region Martinsried
  Country Germany
  Street 19a Am Klopferspitz
  City 82152 Martinsried
    Address record changed: 2014-04-23
     
Basic data Employees n. a.
     
    * Document for �About Section�: Medigene AG. (3/26/14). "Press Release: Medigene’s Dentritic Cell Vaccines Program Strengthened by Issued US Patent". Martinsried.
     
   
Record changed: 2018-10-31

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px




» top